Da An Gene reports mixed financials, negative profit despite R&D focus

Da An Gene of Sun Yat-Sen University reported a 15.44% decrease in operating revenue to CNY 338,574,032.79 for the first half of 2025 compared to the previous year. Despite this, net profit attributable to shareholders saw a significant increase of 54.37% to CNY -182,160,988.30, while net profit excluding non-recurring items decreased by 47.98% to CNY -264,517,382.29. The company's total assets decreased by 4.80% to CNY 9,116,983,627.54, while net assets attributable to shareholders decreased by 2.29% to CNY 7,699,881,768.56.

The company's board of directors, supervisory board, and independent directors have approved adjustments to the 2025 daily related-party transaction forecasts, increasing the total projected amount to CNY 7,453.00, up from the initial CNY 7,353.00. The company also announced changes to its Articles of Association, cancelling the supervisory board and assigning its functions to the board's audit committee to streamline governance and improve efficiency.